Gene · 6755
Papers1,882
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,882
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Predicting Response to Medical Treatment in Acromegaly via Granulation Pattern, Expression of Somatostatin Receptors Type 2 and 5 and E-Cadherin. | Int J Mol Sci | 2024 | 39201352 | PubTator, text mining | PubMed |
| Clinical Evaluation of Response to Octreotide and Chemotherapy in High-Grade Malignant Neuroendocrine Tumors and Promising In Vitro Preclinical Results with Pasireotide. | Medicina (Kaunas) | 2024 | 39064468 | PubTator, text mining | PubMed |
| Somatostatin receptors in fibrotic myocardium. | PLoS One | 2024 | 39038008 | PubTator, text mining | PubMed |
| Structural insights into somatostatin receptor 5 bound with cyclic peptides. | Acta Pharmacol Sin | 2024 | 38926478 | PubTator, text mining | PubMed |
| Structural basis for activation of somatostatin receptor 5 by cyclic neuropeptide agonists. | Proc Natl Acad Sci U S A | 2024 | 38885377 | PubTator, text mining | PubMed |
| Activation of the SST-SSTR5 signaling pathway enhances corneal wound healing in diabetic mice. | Mucosal Immunol | 2024 | 38866206 | PubTator, text mining | PubMed |
| Acute Interstitial Nephritis and Oxalate Nephropathy After Rapid Pasireotide Response in Treatment-resistant Acromegaly. | JCEM Case Rep | 2024 | 38770226 | PubTator, text mining | PubMed |
| The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells. | Int J Mol Sci | 2024 | 38612419 | PubTator, text mining | PubMed |
| Oral SSTR5 Antagonist SCO-240 for Growth Hormone Stimulation: A Phase I Single-Dose Study in Healthy Individuals. | Clin Pharmacol Ther | 2024 | 38549435 | PubTator, text mining | PubMed |
| Immunological signatures and predictive biomarkers for first-generation somatostatin receptor ligand resistance in Acromegaly. | J Neurooncol | 2024 | 38441839 | PubTator, text mining | PubMed |
| Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers. | Clin Exp Med | 2024 | 38294554 | PubTator, text mining | PubMed |
| Unraveling the Whipple Triad: Non-Islet Cell Tumor-Induced Hypoglycemia. | JCEM Case Rep | 2024 | 38283730 | PubTator, text mining | PubMed |
| Functional Classification and Interaction Selectivity Landscape of the Human SH3 Domain Superfamily. | Cells | 2024 | 38275820 | PubTator, text mining | PubMed |
| Transcriptional reprogramming during human osteoclast differentiation identifies regulators of osteoclast activity. | Bone Res | 2024 | 38263167 | PubTator, text mining | PubMed |
| An Overview of Advances in Rare Cancer Diagnosis and Treatment. | Int J Mol Sci | 2024 | 38256274 | PubTator, text mining | PubMed |
The value of color doppler ultrasonography combined with computed tomography angiography and magnetic resonance angiography in the preoperative quantification and classification of carotid body tumors: a retrospective analysis. | BMC Med Imaging | 2024 | 38172706 | PubTator, text mining | PubMed |
| Time-of-day-dependent variation of the human liver transcriptome and metabolome is disrupted in MASLD. | JHEP Rep | 2024 | 38125300 | PubTator, text mining | PubMed |
| A novel somatostatin receptor ligand for human ACTH - and GH -secreting pituitary adenomas. | Eur J Endocrinol | 2024 | 38123488 | PubTator, text mining | PubMed |
| Using AlphaFold and Experimental Structures for the Prediction of the Structure and Binding Affinities of GPCR Complexes via Induced Fit Docking and Free Energy Perturbation. | J Chem Theory Comput | 2024 | 38100422 | PubTator, text mining | PubMed |
| Correlation between tumor invasion and somatostatin receptor subtypes in acromegaly. | J Neurosurg | 2024 | 37856412 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6755/papers?page=4